K160798 is an FDA 510(k) clearance for the IPS e.max® Press Abutment Solutions for Viteo Base Ti. This device is classified as a Abutment, Implant, Dental, Endosseous (Class II - Special Controls, product code NHA).
Submitted by Ivoclar Vivadent, AG (Schaan, LI). The FDA issued a Cleared decision on December 15, 2016, 267 days after receiving the submission on March 23, 2016.
This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3630. To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation..